# Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial

> **NCT05887804** · PHASE4 · COMPLETED · sponsor: **Rumah Sakit Pusat Angkatan Darat Gatot Soebroto** · enrollment: 24 (actual)

## Conditions studied

- Keloid
- Stem Cell

## Interventions

- **BIOLOGICAL:** umbilical cord-derived mesenchymal stem cells (UC-MSC)
- **BIOLOGICAL:** umbilical cord-derived mesenchymal stem cells conditioned medium (UC-CM)
- **DRUG:** Triamcinolone Acetonide (TA)

## Key facts

- **NCT ID:** NCT05887804
- **Lead sponsor:** Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-06-09
- **Final completion:** 2022-06-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05887804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05887804, "Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05887804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*